CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia
European Journal of Haematology · 2025
DOI: 10.1111/ejh.70035 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Haematology, 2025. Verfasst von Tharageswari Srinivasan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India. Hauptthemen laut MEDLINE: Neoplasm, Residual, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Biomarkers, Tumor, CD48 Antigen. Die Arbeit nennt 33 Literaturangaben.
Abstract (Originalsprache)
Objectives
To evaluate the utility of CD48 as a marker to distinguish T‐lymphoblasts from mature T cells and NK cells in T‐lineage acute lymphoblastic leukemia (T‐ALL) for measurable residual disease (MRD) detection by flow cytometry.
Methods
CD48 expression was assessed in T‐lymphoblasts and mature T cells from 51 diagnostic T‐ALL samples and 84 post‐therapy samples. Normalized median fluorescence intensity (nMFI) of CD48 was calculated as the ratio of MFI in the population of interest to that in mature B cells.
Results
At diagnosis, the median CD48 nMFI in T‐lymphoblasts was significantly lower (0.14) compared to mature T cells (1.29) ( p < 0.0001). In MRD‐positive post‐therapy samples, T‐lymphoblasts had a lower nMFI (0.22) than mature T cells (1.4), NK cells (1.06), and γδ T cells (1.09) ( p < 0.0001).
Conclusion
CD48 demonstrates consistent under‐expression in T‐lymphoblasts compared to mature T cells and NK cell cells, supporting its use as a reliable and informative marker for MRD detection in T‐ALL. Its inclusion would enhance the accuracy of flow cytometry‐based MRD panels.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Clinical Hematology and Medical Oncology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
- Department of Paediatrics, Hemato-Oncology Unit, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
ORCID-Profile: Tharageswari Srinivasan, Nabhajit Mallik
Zitieren
APA
Srinivasan, T., Mallik, N., Sachdeva, M. U. S., Bose, P., Kumar, A., Lal, B., Sharma, P., Sreedharanunni, S., Malhotra, P., & Trehan, A. (2025). CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia. European Journal of Haematology. https://doi.org/10.1111/ejh.70035
Vancouver
Srinivasan T, Mallik N, Sachdeva MUS, Bose P, Kumar A, Lal B, et al. CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia. European Journal of Haematology. 2025. doi:10.1111/ejh.70035
BibTeX
@article{Srinivasan2025,
author = {Srinivasan, Tharageswari and Mallik, Nabhajit and Sachdeva, Man Updesh Singh and Bose, Parveen and Kumar, Arun and Lal, Bhavishan and Sharma, Praveen and Sreedharanunni, Sreejesh and Malhotra, Pankaj and Trehan, Amita},
title = {CD48 Is a Robust Marker and a Useful Addition for Assessment of Measurable Residual Disease in T‐Cell Acute Lymphoblastic Leukemia},
journal = {European Journal of Haematology},
year = {2025},
doi = {10.1111/ejh.70035}
}
EUVIMED